Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation - Aix-Marseille Université Access content directly
Journal Articles Bone Marrow Transplantation Year : 2020

Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

Charlotte Nykolyszyn
  • Function : Author
Angela Granata
  • Function : Author
Thomas Pagliardini
  • Function : Author
Luca Castagna
  • Function : Author
Samia Harbi
  • Function : Author
Reda Bouabdallah
  • Function : Author
Norbert Vey
Sabine Fürst
  • Function : Author
Valério Maisano
  • Function : Author
Faezeh Legrand
  • Function : Author
Claude Lemarié
  • Function : Author
Boris Calmels
  • Function : Author
Pierre-Jean Weiller
  • Function : Author

Domains

Immunology

Dates and versions

hal-03152809 , version 1 (25-02-2021)

Identifiers

Cite

Charlotte Nykolyszyn, Angela Granata, Thomas Pagliardini, Luca Castagna, Samia Harbi, et al.. Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation. Bone Marrow Transplantation, 2020, 55 (2), pp.349-355. ⟨10.1038/s41409-019-0682-2⟩. ⟨hal-03152809⟩

Collections

CNRS UNIV-AMU CRCM
21 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More